Blood cancer Clinical Trials in Buffalo, NY
As of June 2026, 49 paid clinical trials are recruiting for Blood cancer in Buffalo, New York. Blood cancer trials investigate CAR-T cell therapies, bispecific antibodies, BTK and BCL-2 inhibitors, and novel combinations across leukemias, lymphomas, myeloma, and myelodysplastic syndromes. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
49 clinical trials for Blood cancer
·Clear filters·↓ Download CSVCommunity-Based Exercise and Nutrition Training and Education Program for Cancer Survivors
Psilocybin With Psychotherapy for Improving Chronic Pain in Cancer Patients Requiring Opioids
Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Mezigdomide, Carfilzomib, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma in Patients With Extramedullary Disease
SX-682 in Combination With Carfilzomib, Daratumumab-Hyaluronidase, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Virtual Reality for Symptom Management in Patients Undergoing Hematopoietic Stem Cell Transplantation
MedSupport Intervention to Identify and Address Barriers to Pediatric Medication Adherence
Follow-Up for Study Participants Treated With an Allogeneic CAR T-Cell Product
A Study of Tagraxofusp in Combination With Venetoclax and Azacitidine in Adults With Untreated CD123+ Acute Myeloid Leukemia Who Cannot Undergo Intensive Chemotherapy
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Community-Based Physical Activity Intervention for Underserved Cancer Survivors
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Tagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide
A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
Low-Intensity Mechanical Stimulation for Hematologic Malignancy Patients
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Study of SGR-1505 in Mature B-Cell Neoplasms
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
About research studies in Buffalo
Buffalo has approximately 465 recruiting research studies across a wide range of therapeutic areas. New York is home to leading academic medical centers such as Memorial Sloan Kettering, Weill Cornell Medicine, Mount Sinai, NYU Langone, and Columbia University Irving Medical Center. These institutions anchor a research ecosystem that covers oncology, cardiology, neurology, and rare disease.
Top Research Study Locations in Buffalo
Researchers run research studies in Buffalo, NY at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Roswell Park Cancer Institute | Acute Myeloid Leukemia, Malignant Solid Neoplasm, Anatomic Stage IV Breast Cancer AJCC v8 | 178 |
| Roswell Park Comprehensive Cancer Center | Acute Myeloid Leukemia, Leukemia, Myeloid, Acute, Myelodysplastic Syndromes | 50 |
| University at Buffalo | Cardiovascular Diseases, Acute Abstinence From Cigarettes vs E-cigarettes (ENDS), Aging | 20 |
| Buffalo General Medical Center | Ischemic Stroke, Acute Ischemic Stroke, Aortic Insufficiency | 10 |
| State University of New York at Buffalo | Acute Ischemic Stroke, Acute Myeloid Leukemia (AML), Birth-weight-for-gestational-age z Score | 9 |
| University of Buffalo | Shoulder Arthritis, Shoulder Fractures, Shoulder Injuries | 9 |
| Roswell Park | Endometrial Cancer, Glioma, MAPK Pathway Gene Mutation | 6 |
| University at Buffalo Neurosurgery | Cerebral Aneurysms, Clinical Need for Cranioplasty, Clinical Need for Craniotomy or Craniectomy | 5 |
| UBMD Pediatrics | Idiopathic Short Stature, Diabetes Mellitus, Type 2, Obesity | 4 |
| VA Western New York Healthcare System, Buffalo, NY | Alcohol-Related Disorders, Brain Concussion, Comorbid Post-Traumatic Stress Disorder and OCD | 4 |
| Erie County Medical Center | Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands, Heart, Heart Failure With Preserved Ejection Fraction (HFPEF) | 4 |
| Jacobs Institute | Aneurysm, Leak, Cerebrospinal Fluid, Moyamoya Disease | 3 |
| Oishei Children's Hospital | Bronchiolitis Acute, Children, Only, Failed or Difficult Intubation, Sequela | 3 |
| University at Buffalo / Great Lakes Cancer Care | Integrative Oncology, Medical Nutrition Therapy, Medical Oncology | 2 |
| Akero Clinical Study Site | MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASH With Fibrosis, NASH - Nonalcoholic Steatohepatitis | 2 |
| Buffalo General | Diastolic Heart Failure, Heart Failure, Heart Failure With Mid Range Ejection Fraction | 2 |
| Circuit Clinical | Hematologic Malignancies, Solid Tumors, Type 1 Diabetes | 2 |
| Dent Neurological Institute | Alzheimer Disease, Dementia, Generalized Myasthenia Gravis | 2 |
| John R. Oishei Children's Hospital | Acute Respiratory Distress Syndrome, Children, Only, Circadian Dysrhythmia | 2 |
| Research Foundation SUNY Buffalo | Aortoiliac Occlusive Disease, PFO - Patent Foramen Ovale, Stroke | 2 |
| Rochester Clinical Research - Buffalo | Obesity, Osteoarthritis, Overweight | 2 |
| Ross Eye Institute, University of Buffalo, Med School Dept Ophthalmology | Amblyopia | 2 |
| SUNY, The University at Buffalo | Deep Venous Thrombosis, Post-Thrombotic Syndrome, Pulmonary Embolism | 2 |
| Sisters of Charity Hospital | Death; Neonatal, Intubation Complication, Percutaneous Coronary Intervention | 2 |
| The Cystic Fibrosis Center of Western New York | Cystic Fibrosis | 2 |
Active & Upcoming Studies in Buffalo (2026)
Recruiting trials in Buffalo grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (220 active studies)
- Transperineal Micro-ultrasound for the Detection of Prostate Cancer During Biopsy · Roswell Park Cancer Institute
- Testing the SurVaxM Vaccine for Lung Cancer Prevention · Phase 2 · National Cancer Institute (NCI)
Neurology & pain (28 active studies)
- Impact of VNS With Rehab on Gait Post-Stroke · State University of New York at Buffalo
- REal-world Clinical evAulation of Medtronic NeurOVascular Products for Acute Ischemic Stroke (RECANOVA Registry) · Medtronic Neurovascular Clinical Affairs
Cardiovascular (24 active studies)
Diabetes & metabolic (23 active studies)
- A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes · Phase 3 · Novo Nordisk A/S
- A Study of Weekly Oral Dose of Ecnoglutide (VRB-101) for Weight Maintenance in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities · Phase 2 · Verdiva Bio Dev Limited
Mental health & behavior (15 active studies)
- Understanding Tobacco and Cannabis Co-Use Practices: Initiation, Escalation, and Maintenance · Roswell Park Cancer Institute
- Influence of Authorized Smokeless Tobacco Product Modified Risk Claims II: Laboratory Assessment of Sensory and Subjective Effects · Roswell Park Cancer Institute
Pediatric (11 active studies)
- Developmental Trajectories of Reinforcer Pathology and Childhood Obesity · State University of New York at Buffalo
- Pain Control Alternatives in Pediatric Patients With Distal Radius Fractures · Phase 3 · State University of New York at Buffalo
Vaccines (3 active studies)
- A Study to Evaluate Safety and Efficacy of TP-05 in Healthy Participants With Tick Exposure · Phase 2 · Tarsus Pharmaceuticals, Inc.
- EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease · Phase 3 · Pfizer
Eye & vision (3 active studies)
- Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial · University of Pennsylvania
- Comparison of Intraocular Pressure Measurement With the Novel TonoVera Device With Other Commonly Used Devices · State University of New York at Buffalo
HIV / STI (2 active studies)
- Examining Migration, Social Bonds, Transnationalism, and HIV Prevention Pathways Among African Immigrants. · State University of New York at Buffalo
- Blood Collection Biorepository for Liver Disease Research · State University of New York at Buffalo
Common conditions studied in Buffalo
- Acute Myeloid Leukemia (15 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Malignant Solid Neoplasm (9 active studies). Recruiting Malignant Solid Neoplasm studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Breast Cancer (7 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Endometrial Cancer (7 active studies). Recruiting Endometrial Cancer studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Anatomic Stage IV Breast Cancer AJCC v8 (6 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Multiple Myeloma (6 active studies). Recruiting Multiple Myeloma studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
Leading research sponsors in Buffalo
- Roswell Park Cancer Institute
- State University of New York at Buffalo
- National Cancer Institute (NCI)
- Children's Oncology Group
- AstraZeneca
Local regulations and guidelines
Clinical trials in New York are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Trials conducted in New York must also comply with the NY SHIELD Act's data-protection requirements and additional oversight from the New York State Department of Health.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Buffalo. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Buffalo
Hipa.ai aggregates every recruiting study in Buffalo from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Buffalo?
There are approximately 465 recruiting clinical trials in Buffalo, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Buffalo pay participants?
Most recruiting trials in Buffalo compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Buffalo?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Buffalo?
The most common conditions under active study in Buffalo include Acute Myeloid Leukemia (15), Malignant Solid Neoplasm (9), Breast Cancer (7), Endometrial Cancer (7), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Buffalo?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Buffalo on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Buffalo?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Buffalo?
Recruiting research sites in Buffalo include Roswell Park Cancer Institute, Roswell Park Comprehensive Cancer Center, University at Buffalo, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Buffalo right now?
The largest active categories in Buffalo are Cancer & tumors (220), Neurology & pain (28), Cardiovascular (24). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.